Pratima Mbbs Thapa
Pratima Mbbs Thapa has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
A Thapa
School of Health and Allied Sciences, Pokhara University, Lekhnath, Kaski
1 shared publication- Abhinav Poudel
Faculty of Agriculture, Agriculture and Forestry University, Rampur, Chitwan, Nepal
1 shared publication - Bikash Manandhar
Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW 2007, Australia
1 shared publication - Bimarsh Acharya
KIST Medical College and Teaching Hospital, Lalitpur, Nepal
1 shared publication D Laudari
School of Health and Allied Sciences, Pokhara University, Lekhnath, Kaski
1 shared publicationHb Malla
School of Health and Allied Sciences, Pokhara University, Lekhnath, Kaski
1 shared publication
Latest Publications
- Open Access
- 17 February 2023
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 85 (3) , 498-501
Guillain-Barré syndrome following the second dose of COVID AstraZeneca vaccine in a 78-year-old male: a case report from Nepal
Introduction and Importance: Guillain-Barré syndrome (GBS) is a rare acute idiopathic demyelinating polyneuropathy that causes bilateral, symmetrical, and progressive weakness of muscles. AstraZeneca vaccine is a genetically modified spike glycoprotein vaccine of an adenovirus vector. GBS following the second dose of the AstraZeneca vaccine dose is rare and not frequently noted. Case Presentation: A 78-year-old male presented to the hospital with complaints of bilateral weakness of the lower limbs over 4 days following the second dose of the AstraZeneca vaccine. On examination, the power and tone of the limbs were diminished. The sensitivity pinprick test revealed low sensitivity in the right lower limb than in the left lower limb. Nerve conduction studies revealed acute inflammatory demyelinating polyneuropathy and the patient was diagnosed with GBS. After admission, the patient was successfully treated with intravenous immunoglobulins along with physiotherapy. Clinical Discussion: GBS can be diagnosed clinically with nerve conduction studies and Brighton’s criteria. The robust causal relationships between COVID-19 infections, COVID-19 vaccination, and GBS are still unclear. The evaluation of the potential association and risk of GBS with vaccines warrants the need for precise post-vaccination surveillance measures and results. Conclusion: Only a few cases of GBS following the second dose of AstraZeneca are reported so far and there is a need for strong and accurate diagnosis of the disease and proper post-vaccination surveillance for the evaluation of risk associated with COVID vaccines.
- 17 February 2023
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 85 (3) , 498-501
Open AccessGuillain-Barré syndrome following the second dose of COVID AstraZeneca vaccine in a 78-year-old male: a case report from Nepal
Introduction and Importance: Guillain-Barré syndrome (GBS) is a rare acute idiopathic demyelinating polyneuropathy that causes bilateral, symmetrical, and progressive weakness of muscles. AstraZeneca vaccine is a genetically modified spike glycoprotein vaccine of an adenovirus vector. GBS following the second dose of the AstraZeneca vaccine dose is rare and not frequently noted. Case Presentation: A 78-year-old male presented to the hospital with complaints of bilateral weakness of the lower limbs over 4 days following the second dose of the AstraZeneca vaccine. On examination, the power and tone of the limbs were diminished. The sensitivity pinprick test revealed low sensitivity in the right lower limb than in the left lower limb. Nerve conduction studies revealed acute inflammatory demyelinating polyneuropathy and the patient was diagnosed with GBS. After admission, the patient was successfully treated with intravenous immunoglobulins along with physiotherapy. Clinical Discussion: GBS can be diagnosed clinically with nerve conduction studies and Brighton’s criteria. The robust causal relationships between COVID-19 infections, COVID-19 vaccination, and GBS are still unclear. The evaluation of the potential association and risk of GBS with vaccines warrants the need for precise post-vaccination surveillance measures and results. Conclusion: Only a few cases of GBS following the second dose of AstraZeneca are reported so far and there is a need for strong and accurate diagnosis of the disease and proper post-vaccination surveillance for the evaluation of risk associated with COVID vaccines.
- Open Access
- 13 August 2013
- Published by Chitwan Medical College in Journal of Chitwan Medical College
- Vol. 3 (2) , 16-19
Causative Agents and Susceptibility of Antimicrobials among Suspected Females with Urinary Tract Infection in Tertiary Care Hospitals of Western Nepal
Urinary Tract Infection (UTI) is a common and serious health problem affecting many people each year around the World especially females. Therapy of UTI relies on the predictability of the agents causing UTI and knowledge of their antimicrobial susceptibility patterns. A retrospective cross-sectional study was conducted in two major hospitals of Western Nepal. Tools for data collection were a data collection form. Total 400 patient’s file with suspected UTI were reviewed, out of which 173 (43.3 %) of the suspected samples showed presence of potential pathogens causing UTI. UTI was mostly prevalent in females of age group 21-30. Escherichia coli (E. coli) was the predominant (65.1%) bacterial pathogen. Amikacin was found to be most sensitive antimicrobial followed by Nitrofurantoin and Gentamcin. Ampicillin showed the higher percentage of resistant, compared to other antimicrobials. As drug resistance among bacterial pathogens is an evolving process, regular surveillance and monitoring is necessary to provide effective treatment of UTIs. DOI: http://dx.doi.org/10.3126/jcmc.v3i2.8436 Journal of Chitwan Medical College Vol.3(2) 2013 16-19
- 13 August 2013
- Published by Chitwan Medical College in Journal of Chitwan Medical College
- Vol. 3 (2) , 16-19
Open AccessCausative Agents and Susceptibility of Antimicrobials among Suspected Females with Urinary Tract Infection in Tertiary Care Hospitals of Western Nepal
Urinary Tract Infection (UTI) is a common and serious health problem affecting many people each year around the World especially females. Therapy of UTI relies on the predictability of the agents causing UTI and knowledge of their antimicrobial susceptibility patterns. A retrospective cross-sectional study was conducted in two major hospitals of Western Nepal. Tools for data collection were a data collection form. Total 400 patient’s file with suspected UTI were reviewed, out of which 173 (43.3 %) of the suspected samples showed presence of potential pathogens causing UTI. UTI was mostly prevalent in females of age group 21-30. Escherichia coli (E. coli) was the predominant (65.1%) bacterial pathogen. Amikacin was found to be most sensitive antimicrobial followed by Nitrofurantoin and Gentamcin. Ampicillin showed the higher percentage of resistant, compared to other antimicrobials. As drug resistance among bacterial pathogens is an evolving process, regular surveillance and monitoring is necessary to provide effective treatment of UTIs. DOI: http://dx.doi.org/10.3126/jcmc.v3i2.8436 Journal of Chitwan Medical College Vol.3(2) 2013 16-19